Advances in Severe Asthma Perspectives From San Antonio 2015

Slides:

Advertisements

Similar presentations

내과 R2 이지영. INTRODUCTION  Asthma  Allergic airway inflammation,Th2-weighted process  Biomarkers  Phenotypic distinctions  Development of personalized.

Advertisements

Asthma Yardstick Annals of Allergy, Asthma & Immunology

Volume 100, Issue 11, Pages (November 2006)

Moderate-to-Severe Asthma Management

Overview The Burden of COPD Main Challenges in the Diagnosis of COPD.

Practical Recommendations for COPD:

The Effect of Intra-Articular Steroids on Cartilage in Knee Osteoarthritis.

Antonio Anzueto, MD, Marc Miravitlles, MD CHEST

The Role of Anticholinergic Therapy in Moderate to Severe Asthma

Management of Mild to Moderate Asthma

Diagnosis, Evaluation, and Therapy for Severe Refractory Eosinophilic Asthma.

Challenges in the Diagnosis of MS: Physician and Nurse Perspectives

Progression After Cancer Immunotherapy in Advanced NSCLC

COPD Management.

Clinical Review.

Stepping Up Asthma Control for Effective Management

Improving Acne Outcomes

Biological Therapy in Psoriasis: Recognizing the Value

Determining the Best Treatment Algorithm for Patients With Head and Neck Cancer.

Chronic Idiopathic Urticaria

Addressing Disease Burden in Asthma

Expert Tips for Tackling Atopic Dermatitis in Pediatric Practice

Overview. Maximizing the Safety of CAR T-Cell Therapy: Prevention, Early Recognition, and Management.

Multidisciplinary Perspectives on Interstitial Lung Diseases

Patient Case: KC. Optimizing Treatment of Mild to Moderate Ulcerative Colitis: A Case-Based Perspective.

Contemporary Issues in Psoriasis Care: A Call to Action

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.

Advances in Cystic Fibrosis: Perspectives from Phoenix 2015

Targeting Osteoporosis Therapies to Patients at Highest Risk for Fracture.

Gene Therapy: Past, Present, and Future

Impactful Data in TD That Can Guide Treatment Decisions

Advancing the Treatment of IBD With Biologics

When Is Biologic Therapy Appropriate for HS?

Management of Systematic Lupus Erythematosus

The Evolving Treatment Landscape in Atopic Dermatitis

Expert Perspectives on the Clinical Use of Immune Reconstitution vs Escalation Therapy for MS.

Background. Advancing the Care of Patients With Moderate to Severe Atopic Dermatitis: A Case-Based Discussion.

Advances in Severe Asthma Management

Cancer-Associated Thrombosis

CAD and HF Often Coexist

Managing HF in Primary Care

Optimizing Outcomes in Crohn Disease

Effects of reslizumab on asthma quality of life questionnaire (AQLQ) score in Global Initiative for Asthma (GINA) Step 4 and 5 patients. Effects of reslizumab.

Patient Questions and Expert Answers in Psoriasis:

Severe Asthma and Comorbidities

The Changing Field of Melanoma: Ipilimumab.

Add-On Therapy to Insulin in T1DM Management

A Nursing Perspective on Improving Outcomes for Patients With Hemophilia.

Patient and Clinician Perspectives on Preventive Therapy for Migraine

Diagnosis, Evaluation, and Therapy for Severe Refractory Eosinophilic Asthma.

Effects of reslizumab on asthma control questionnaire-7 (ACQ-7) score in Global Initiative for Asthma (GINA) Step 4 and 5 patients. Effects of reslizumab.

The Journal of Allergy and Clinical Immunology: In Practice

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the United States, and data.

The Nurse View: Spotlight on Immune Checkpoint Inhibitors in Advanced Lung Cancer.

Quality Improvement and Molecular Profiling in Advanced Non-Small Cell Lung Cancer.

Pathogenesis of IBD, and the Role of Biologic Therapies

Checkpoint Inhibitors in First-Line Advanced NSCLC

PAH Pathways: What Do the Data Tell Us?”

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.

Immune Checkpoint Inhibitors in Lung Cancer

Practical Recommendations for COPD:

Where Does Anticholinergic Therapy Fit in Moderate to Severe Asthma?

Supplementary Fig.1. The flow of the subjects.

The Asthma Treatment Gap

Comparative Studies of Biologics in Ulcerative Colitis

Pre-K Classes in San Antonio | Pre-K San Antonio | Discovery World Learning Center

Selective Immunomodulation in MS

Foundations of Asthma.

Presentation transcript:

Advances in Severe Asthma Perspectives From San Antonio 2015

Advances in Severe Asthma Perspectives From San Antonio 2015

QD Tiotropium Add-On Therapy

QD Tiotropium Add-On Therapy Findings

QD Tiotropium Add-On Therapy Conclusion

Immunosuppression From Systemic Steroid Bursts

Immunosuppression From Systemic Steroid Bursts

Advances in Severe Asthma Perspectives From San Antonio 2015

TENOR 2 Background/Methods

TENOR 2 Findings

Exhaled Nitric Oxide Utilization Study

Uses of Exhaled Nitric Oxide

Future Direction for Patients With Poorly Controlled Severe Persistent Asthma?

Advances in Severe Asthma Perspectives From San Antonio 2015

Flunisolide HFA

Flunisolide HFA (cont)

Effect of Roflumilast on Asthma-COPD Overlap Syndrome (ACOS)

Effect of Roflumilast on ACOS (cont)

Advances in Severe Asthma Perspectives From San Antonio 2015

Immunomodulators in Severe Asthma

Reslizumab Open-Label Extension on AQLQ Scores

Investigational Biologics for Severe Asthma

Abbreviations